BXT-51072

· Synvista Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BXT-51072, covering 2008-08-25 to 2008-08-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI) [Phase 2]